SEARCH

SEARCH BY CITATION

References

  • Adam A., Smith L. L. and Cohen G. M. (1990) An assessment of the role of redox cycling in mediating the toxicity of paraquat and nitrofurantoin. Environ. Health Perspect. 85, 113117.
  • Altar C. A., Heikkila R. E., Manzino L. and Marien M. R. (1986) Eur. J. Pharmacol. 131, 199209.
  • Ambudkar S. V., Dey S., Hrycyna C. A., Ramachandra M., Pastan I. and Gottesman M. M. (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39, 361398.
  • Bachurin S. O., Shevtzova E. P., Lermontova N. N., Serkova T. P. and Ramsay R. R. (1996) The effect of dithiocarbamates on neurotoxic action of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and on mitochondrial respiration chain. Neurotoxicology 17, 897904.
  • Bliss C. I. (1939) The toxicity of poisons applied jointly. Ann. Appl. Biol. 26, 585615.
  • Brooks A. I., Chadwick C. A., Gelbard H. A., Cory-Slechta D. A. and Federoff H. J. (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 823, 110.
  • Busch A. E., Karbach U., Miska D., Gorboulev V., Akhoundova A., Volk C., Arndt P., Ulzheimer J. C., Sonders M. S., Baumann C., Waldegger S., Lang F. and Koepsell H. (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol. Pharm. 54, 342352.
  • Cassee F. R., Groton J. P., Van Bladeren P. J. and Feron V. J. (1998) Crit. Rev. Toxicol. 28, 73101.
  • Chan B. S. H., Lazzaro V. A., Seale J. P. and Duggin G. G. (1996) Transport of paraquat in a renal epithelial cell line LLC-PK1. J. Pharmacol. Exp. Ther. 279, 625632.
  • Chiba K. and Trevor A. J. and Castagnoli N. Jr (1985) Active transport of MPP+, a metabolite of MPTP by brain synaptosomes. Biochem. Biophys. Res. Comm. 128, 12281232.
  • Corsini G. U., Pintus S., Chiueh C. C., Weiss J. F. and Kopin I. J. (1985) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate. Eur. J. Pharmacol. 119, 127128.
  • Di Monte D. A., McCormack A. L., Langston J. W., Thiruchelvam M. and Cory-Slechta D. A. (2001) Paraquat induced cell loss in the mouse substantia nigra. Toxicologist 60, 54.
  • Diliberto P. A., Jeffs R. A. and Cubeddu L. (1988) X. Effects of low extracellular chloride on dopoamine release and the dopamine transporter. J. Pharmacol. Exp. Ther. 248, 644653.
  • Doolen S. and Zahniser N. R. (2001) Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J. Pharmacol. Exp. Ther. 296, 931938.
  • Dot J., Lluch M., Blanco I. and Rodriguez-Alvarez J. (2000) Polyamine uptake in cultured astrocytes: characterization and modulation by protein kinases. J. Neurochem. 75, 19171926.
  • Drew R., Siddik Z. H. and Gram T. E. (1979) Uptake and efflux of 14C-paraquat by rat lung slices. The effect of imipramine and other drugs. Toxicol. Appl. Pharmacol. 49, 473478.
  • Endo A., Kano S. and Kuriiwa F. (1988) Effects of paraquat containing herbicide Gramoxon, on the central monoamines and acetylcholine in mice. Res. Commun. Psychol. Psychiatr. Behav. 13, 261270.
  • De La Fuente-Fernández R. and Calne D. B. (2002) Evidence for environmental causation of Parkinson's disease. Parkinsonism Related Disorders 8, 235241.
  • Gilad G. M. and Gilad V. H. (1991) Polyamine uptake, binding and release in rat brain. Eur. J. Pharmacol. 193, 4146.
  • Groves C. E., Morales M. N., Gandolfi A. J., Dantzler W. H. and Wright S. H. (1995) Peritubular paraquat transport in isolated renal proximal tubules. J. Pharmacol. Exp. Ther. 275, 926932.
  • Harman R. J. and Shaw G. G. (1981) High-affinity uptake of spermine by slices of rat cerebral cortex. J. Neurochem. 36, 16091615.
  • Hertzman C., Wiens M., Bowering D., Snow B. and Calne D. (1990) Parkinson's disease: a case-control study of occupational and environmental risk factors. Am. J. Ind Med. 17, 349355.
  • Holland I. B. and Blight M. A. (1999) ABC-ATPases, adaptable energy generators fueling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J. Mol. Biol. 293, 381399.
  • International Programme on Chemical Safety (2001) Dithiocarbamate pesticides, ethlylenethiourea and propylthiourea: a general introduction. Environmental Health Criteria78, 159.
  • Irwin I., Wu E. Y., DeLanney L. E., Trevor A. and Langston J. W. (1987) The effect of dithiocarbamate on the biodisposition of MPTP: an explanation for enhanced neurotoxicity. Eur. J. Pharmacol. 141, 209217.
  • Jack D. L., Paulsen I. T. and Saier M. H. Jr (2000) The amino acid/polyamine/organocation (APC) superfamily of transporters specific for amino acids, polyamines and organocations. Microbiology 146, 17971814.
  • Javitch J. J., D'Amato R. J., Strittmatter S. M. and Snyder S. S. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl Acad. Sci. USA 82, 21732177.
  • Johannessen J. N., Chiueh C. C., Burns R. S. and Markey S. P. (1985) Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects. Life Sci. 36, 219224.
  • Keeling P. L. and Smith L. L. (1982) Relevance of NADPH depletion and mixed disulphide formation in rat lung to the mechanism of cell damage following paraquat administration. Biochem. Pharmacol. 31, 32433249.
  • Kitayama S., Mitsuhata C., Davis S., Wang J. B., Sato T., Morita K., Uhl G. R. and Dohi T. (1998) MPP+ toxicity and plasma membrane dopamine transporter study using cell lines expressing the wild-type and mutant rat dopamine transporters. Biochim. Biophys. Acta 1404, 305313.
  • Lau Y.-S., Trobough K. L., Crampton J. M. and Wilson J. A. (1990) Effects of probenecid on striatal dopamine depeletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPYP)-treated mice. Gen. Pharmacol. 21, 181187.
  • Leslie E. M., Deely R. G. and Cole S. P. C. (2001) Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167, 323.
  • Liou H. H., Tsai M. C., Chen C. J., Jeng J. S., Chang Y. C., Chen S. Y. and Chen R. C. (1997) Environmental risk factors and Parkinson's disease: a case–control study in Taiwan. Neurology 48, 15831588.
  • Lonart G. and Zigmond M. J. (1991) High glutamate concentrations evoke Ca++-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J. Pharmacol. Exp. Ther. 256, 11321138.
  • Maroni M., Colosio C., Ferioli A. and Fait A. (2000) Biological monitoring of pesticide exposure: a review. Toxicology 143, 4751.
  • McCormack A. L., Thiruchelvam M., Manning-Bog A. B., Thiffault C., Langston J. W., Cory-Slechta D. A. and Di Monte D. A. (2002) Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 10, 119127.
  • McGrew D. M., Irwin I. and Langston J. W. (2000) Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice. Neurotoxicology 21, 309312.
  • Meco G., Bonifati V., Vanacore N. and Fabrizio E. (1994) Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). Scand. J. Work Environ. Health 20, 301305.
  • Miller D. B., Reinhard J. F., Daniels A. J. and O'Callaghan J. P. (1991) Diethyldithiocarbamate potentiates the neurotoxicity of in vivo MPTP and of in vitro MPP+. J. Neurochem. 57, 541549.
  • Perry T. L., Yong V. W., Wall R. A. and Jones K. (1986) Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse. Neurosci. Lett. 69, 285289.
  • Poirier J., Kogan S. and Gauthier S. (1991) Environment, genetics and idiopathic Parkinson's disease. Can. J. Neurol. Sci. 18, 7076.
  • Raiteri M., Cerrito F., Cervoni A. M. and Levi G. (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208, 195202.
  • Richfield E. K. (1992) Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake complex. Mol. Pharm. 43, 100108.
  • Rose M. S., Lock E. A., Smith L. L. and Wyatt I. (1976) Paraquat accumulation tissue and species specificity. Biochem. Pharmacol. 25, 419423.
  • Sanchez-Ramos J. R., Hefti F. and Weiner W. J. (1987) Paraquat and Parkinson's disease. Neurology 37, 728.
  • Schoemaker H. and Nickolson V. J. (1982) Interaction between dopamine influx and efflux in rat striatal synaptosomes. Life Sci. 22, 24552461.
  • Schoemaker H. and Nickolson V. J. (1983) Dopamine uptake by rat striatal synaptosomes: a compartmental analysis. J. Neurochem. 41, 684690.
  • Semchuk K. M., Love E. J. and Lee R. G. (1991) Parkinson's disease and exposure to rural environmental factors: a population based case-control study. Can. J. Neurol. Sci. 18, 279286.
  • Semchuk K. M., Love E. J. and Lee R. G. (1992) Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42, 13281335.
  • Smith L. L. (1988) The toxicity of paraquat. Advance Drug Reaction 1, 117.
  • Smith L. L. and Wyatt I. (1981) The accumulation of putrescine into slice of rat lung and brain and its relationship to the accumulation of paraquat. Biochem. Pharmacol. 30, 10531058.
  • Smith L. L., Rose M. S. and Wyatt I. (1978) The pathology and biochemistry of paraquat. Ciba Foundation Symp. 65, 321341.
  • Smith L. L., Wyatt I. and Cohen G. M. (1982) The accumulation of diamines and polyamines into rat lung slices. Biochem. Pharmacol. 31, 32093033.
  • Snyder S. H. and D'Amato R. J. (1985) Predicting Parkinson's disease. Nature 317, 198199.
  • Takahashi R. N., Rogerio R. and Zanin M. (1989) Maneb enhances MPTP neurotoxicity in mice. Res. Com. Chem. Pathol. Pharmacol. 66, 167170.
  • Tanner C. M. (1989) The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci. 12, 4954.
  • Tanner C. M., Ottman R., Goldman S. M., Ellenberg J., Chan P., Mayeux R. and Langston J. W. (1999) Parkinson disease in twins: an etiologic study. JAMA 281, 341346.
  • Taylor E. M. (2002) The impact of efflux transporters in the brain on the development of drugs for CNS disorders. Clin. Pharmacokinet. 41, 8192.
  • Thiruchelvam M., Brockel B. J., Richfield E. K., Baggs R. B. and Cory-Slechta D. A. (2000a) Potential and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease. Brain Res. 873, 225234.
  • Thiruchelvam M., Richfield E. K., Baggs R. B., Tank A. W. and Cory-Slechta D. A. (2000b) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 20, 92079214.
  • Thiruchelvam M., Richfield E. K., Goodman B. M., Baggs R., Di Monte D. A. and Cory-Slechta D. A. (2002) Developmental exposure to the pesticides paraquat and maneb and the Parkisnon's disease phenotype. Neurotoxicology 23, 621633.
  • Thiruchelvam M., McCormack A., Richfield E. K., Baggs R., Tank A. W., Di Monte D. A. and Cory-Slechta D. A. Age-related irreversible nigrostriatal dopaminergic neurotoxicity following exposure pesticides paraquat maneb. (submitted)
  • Vaccari A., Saba P. L., Ruiu S., Collu M. and Devoto P. (1996) Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine. Toxicol. Appl. Pharmacol. 139, 102108.
  • Walker Q. D. and Mailman R. (1996) B. Triadimefon and Triadimenol effects on monoamine uptake and release. Toxicol. Appl. Pharmacol. 139, 227233.
  • Walters T. L., Irwin I., Delfani K., Langston J. W. and Janson A. M. (1999) Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP. Exp. Neurol. 156, 6270.
  • Wesseling C., De Joode B. V. W., Ruepert C., Leon C., Monge P., Hermosillo H. and Partanen T. J. (2001) Paraquat in developing countries. Int. J. Occup. Environ. Health 7, 275286.
  • Widdowson P. S., Farnworth M. J., Upton R. and Simpson M. G. (1996) No change in behaviour, nigrostriatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats. Hum. Exp. Toxicol. 15, 583591.
  • Witschi H., Kacew S., Hirai K. and Cote M. G. (1977) In vivo oxidation of reduced nicotinamide-adenine dinucleotide phosphate by paraquat and diquat in rat lung. Chem. Biol. Interactions 19, 143160.
  • Woolley D. E., Gietzen D. W., Gee S. J., Magdalou J. and Hammock B. D. (1989) Does paraquat (PQ) mimic MPP+ toxicity? Proc. West. Pharmacol. Soc. 32, 191193.
  • Wu X., Kekuda R., Huang W., Fei Y. J., Leibach F. H., Chen J., Conway S. J. and Ganapathy V. (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J. Biol. Chem. 273, 3277632786.
  • Yang W. and Sun A. Y. (1998) Paraquat-induced free radical reaction in mouse brain microsomes. Neurochem. Res. 23, 4753.
  • Yurek D. M., Deutch A. Y., Roth R. H. and Sladek J. R. (1989) Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Brain Res. 497, 250259.
  • Zhang L., Dresser M. J., Gray A. T., Yost S. C., Terashita S. and Giacomini K. M. (1997) Cloning and functional expression of a human liver organic cation transporter. Mol. Pharmacol. 51, 913921.
  • Zuddas A., Corsini G. U., Schinelli S., Barker J. L., Kopin I. J. and Di Porzio U. (1989a) Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum. Brain Res. 501, 1122.
  • Zuddas A., Corsini G. U., Schinelli S., Johannessen J. N., Di Porzio U. and Kopin I. J. (1989b) MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra. Brain Res. 501, 110.